UBM (UBM) Given Outperform Rating at BNP Paribas

BNP Paribas reaffirmed their outperform rating on shares of UBM (LON:UBM) in a report published on Thursday morning.

Several other equities analysts have also recently issued reports on UBM. Peel Hunt reissued an add rating and set a GBX 960 ($13.48) target price on shares of UBM in a research note on Monday, March 5th. Shore Capital reissued a buy rating on shares of UBM in a research note on Wednesday, January 17th. Deutsche Bank reissued a hold rating on shares of UBM in a research note on Wednesday, January 17th. Finally, Liberum Capital reissued a hold rating and set a GBX 760 ($10.67) target price on shares of UBM in a research note on Tuesday, January 16th. Eight equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company presently has an average rating of Hold and a consensus price target of GBX 868.36 ($12.19).

How to Become a New Pot Stock Millionaire

Shares of UBM stock opened at GBX 943.50 ($13.24) on Thursday. UBM has a one year low of GBX 639 ($8.97) and a one year high of GBX 957.50 ($13.44).

The company also recently declared a dividend, which will be paid on Thursday, May 24th. Investors of record on Thursday, April 19th will be given a dividend of GBX 18 ($0.25) per share. The ex-dividend date of this dividend is Thursday, April 19th. This is a positive change from UBM’s previous dividend of $5.50. This represents a dividend yield of 1.96%.

In other news, insider Terry Neil purchased 585 shares of the company’s stock in a transaction that occurred on Wednesday, February 28th. The shares were bought at an average cost of GBX 919 ($12.90) per share, for a total transaction of £5,376.15 ($7,546.53). Also, insider Tim Cobbold sold 117,272 shares of UBM stock in a transaction that occurred on Tuesday, March 6th. The shares were sold at an average price of GBX 930 ($13.05), for a total value of £1,090,629.60 ($1,530,923.08). Insiders have purchased 638 shares of company stock worth $583,286 over the last 90 days.

ILLEGAL ACTIVITY WARNING: This article was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/3339952/ubm-ubm-given-outperform-rating-at-bnp-paribas.html.

UBM Company Profile

UBM plc is a business-to-business (B2B) event organizer. The Company’s segments include Events and Other Marketing Services. In total, the Company serves over 50 different communities. The Company operates in over 20 countries. Events segment provide face-to-face interaction in the form of exhibitions, tradeshows, conferences and other live events.

Analyst Recommendations for UBM (LON:UBM)

Receive News & Ratings for UBM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UBM and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Proteostasis Therapeutics  Stock Price
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Proteostasis Therapeutics Stock Price
FTD Companies  Getting Somewhat Positive Press Coverage, Report Shows
FTD Companies Getting Somewhat Positive Press Coverage, Report Shows
Koovs  Stock Price Up 28.2%
Koovs Stock Price Up 28.2%
Rigel Pharmaceuticals   Shares Down 6.5%
Rigel Pharmaceuticals Shares Down 6.5%
Dicerna Pharmaceuticals  Shares Up -6.6%
Dicerna Pharmaceuticals Shares Up -6.6%
Barnes & Noble  & Big 5 Sporting Goods  Head to Head Review
Barnes & Noble & Big 5 Sporting Goods Head to Head Review


© 2006-2018 Ticker Report. Google+.